Business
Govt, Private Sector Can Keep Tariff Disruptions To Minimum: FinMin Economic Review
New Delhi: While near-term risks to economic activity, principally exports and capital formation remain due to tariff-related uncertainties, the government and the private sector, acting in tandem and concert, can keep the disruptions to a minimum, the Finance Ministry’s ‘Monthly Economic Review’ said on Wednesday. Going ahead, the robust macroeconomic fundamentals continue to bolster the resilience of the Indian economy.
“Setbacks eventually make us stronger and more agile, if handled properly. If the near-term economic pain is absorbed more by those who have the ability and the financial strength to do so, then small and medium enterprises in downstream industries will emerge stronger from the trade imbroglio. Now is the time to demonstrate an understanding of national interest,” according to the ‘Monthly Economic Review July 2025’.
The government’s recent policy initiatives, including the setting up of a Task Force for Next-Generation Reforms and the forthcoming GST reforms, deregulation initiatives of the States, coupled with the sovereign rating upgrade, are set to reduce borrowing costs, attract foreign capital, and bolster investment and consumption.
“These reforms mark the beginning of an accelerated phase of governance transformation, ensuring that India extends its own line of progress, becoming more resilient, inclusive, and globally competitive in an era of rising global economic self-interest,” the Review further stated. The US administration has imposted a hefty 50 per cent tariffs on Indian goods, a move touted as the ‘economic blackmail’.
According to the Economic Review, robust macroeconomic performance and sound fundamentals over the past few years have earned India a well-deserved sovereign rating upgrade by the S&P credit rating agency to ‘BBB’.
“The rating upgrade underscores India’s resilient growth, anchored inflation expectations, and stronger credit metrics, underpinned by fiscal consolidation and improved quality of spending. Building on the growth momentum gained during Q1 of FY26, the Indian economy continues to reflect resilience in July 2025,” it noted.
Record e-way bill generation and a 16-month high in PMI manufacturing point to robust business activity. Further, the stronger expansion in the services PMI indicates growth in the services activity. Domestic demand remained buoyant, as reflected in FMCG sales, UPI transactions, and vehicle sales, supported by strong rural consumption, strengthening urban demand and favourable monsoon conditions.
Forward-looking surveys of the Reserve Bank of India (RBI) signal broad-based improvements in business conditions, with rising capacity utilisation, stable inventories, and optimistic expectations across manufacturing, services, and infrastructure, underscoring sustained confidence in economic activity.
Fiscal performance during Q1 of FY26 reflects a strong capex push, with robust growth in capital expenditure alongside healthy revenue growth driven primarily by non-tax receipts. In July 2025, India’s total exports (goods and services) recorded a growth rate of 4.5 per cent (YoY), driven primarily by a 12.7 per cent growth (YoY) in core merchandise exports.
As of August 08, 2025, the foreign exchange reserves stand at a comfortable level of $695.1 billion, providing an import cover of 11.4 months. “In the dynamic global trade landscape, India has adopted a calibrated approach to negotiating FTAs, aiming to expand market access while protecting domestic interests. Recently, two major agreements, the India-UK CETA and the India-EFTA TEPA, have been concluded, and negotiations continue with a few other nations,” said the Economic Review.
Mumbai: The shares of InterGlobe Aviation, the parent company of IndiGo Airlines, tanked over 4 per cent in the early trading on Thursday on news of promoter Rakesh Gangwal’s family selling stocks worth Rs 7,085 crore through a block deal.
At around 11:38 am, the shares were trading at Rs 5,789.0, down 4.31 per cent or Rs 261.
The promoter family is likely to sell 1.2 lakh shares, worth Rs 7,085 crore, at an average price of Rs 5,830 per share.
(Also Read: Key Financial Rules Changing From September 2025)
According to earlier media reports, the Gangwal family plans to sell up to 3.1 per cent of InterGlobe Aviation through block deals valued at approximately Rs 7,020 crore.
A floor price of Rs 5,808 per share, or about 4 per cent less than the closing price of the previous session, was anticipated for the block deal.
With this, the family’s persistent withdrawal from IndiGo continues.
They have been reducing their stake in the airline since Rakesh Gangwal left the board in February 2022; as of 2025, they have sold almost 9 per cent of the company.
(Also Read: What Is GST Compensation Cess? GST Council May End It By October 31)
By reducing their ownership of InterGlobe Aviation, Rakesh Gangwal and his family have raised more than Rs 45,300 crore since 2022.
In September 2022, a 2.74 per cent stake worth Rs 2,005 crore was sold. In February 2023, his wife, Shobha Gangwal, sold a 4 per cent stake for Rs 2,944 crore, and in August 2023, a further 2.9 per cent stake was sold for slightly more than Rs 2,800 crore.
Despite a 4.7 per cent increase in revenue, IndiGo recently reported a 20 per cent year-over-year drop in net profit for the first quarter of FY26, with earnings of Rs 2,176 crore.
Higher fuel prices, exchange rate fluctuations, and other external factors were the primary causes of the decline in profitability.
However, the airline continued to demonstrate strong operational performance, as evidenced by its 84.2 per cent passenger load factor and 87.1 per cent on-time performance.
Business
Top stocks to buy today: Stock recommendations for August 28, 2025 – check list – The Times of India
Top stock market recommendations: According to Aakash K Hindocha, Deputy Vice President – WM Research, Nuvama Professional Clients Group, Nykaa, Kaynes, and Dr Reddy’s Laboratories are the top buy calls for today. Here’s his view on Nifty, Bank Nifty and the top stock picks for August 28, 2025:Index View: NiftyAfter an inside bar formation on Monday, Nifty opened with a gap down reeling all throughout the session ahead of its trading holiday on Wednesday. The index has closed below its trailing support of 24800 allowing for further downside to be opened for 24500 / 24350. Nifty has also formed a bearish head and shoulders formation on daily charts with a neck line support seen at 24450. A break below the same post monthly expiry could reel in further pressure on the index.Bank NiftyUnderperforming Nifty, Bank has broken its support of 55050 opening for a test of sub 54000 odd levels to begin with. The index has also closed at a 3.5 month low on daily charts ahead of its monthly expiry scheduled on Thursday. 55000 is likely to act as resistance on the upside while the index slides below sub 54000 levels in the coming week.NYKAA (BUY):
- LCP: 231.65
- Stop Loss: 223
- Target: 252
Stock has been gaining traction ever since its 3 year triangle breakout seen in June 2025. For now NYKAA has given the highest ever close in past 3 years of trading along with a huge cup and handle breakout on daily and weekly charts. This opens up for a 18-20% trading buy target on the stock, yet we would advise for an initial uptick being 250+ on this leg.KAYNES (BUY):
- LCP: 6197
- Stop Loss: 5980
- Target: 6620
After a cup and handle breakout in early August 2025, stock has been consolidating near the breakout zone for the past 4 weeks now. Last week’s price action suggests further move northwards from CMP as the stock has completed multiple retests of its ongoing breakout.Dr Reddy’s Laboratories (BUY):
- LCP: 1263
- Stop Loss: 1230
- Target: 1355
Sustaining above its 200 DMA support, DRREDDY’s has also given a bullish flag breakout on daily charts. This allows its initial upside to open for the 1350-1360 zone where it could meet another potential breakout on upside.(Disclaimer: Recommendations and views on the stock market and other asset classes given by experts are their own. These opinions do not represent the views of The Times of India)
Business
White House fires CDC director Monarez after she refuses to resign; 4 top health officials quit
Susan Monarez, President Donald Trump’s nominee to be the Director of the Centers for Disease Control and Prevention (CDC), testifies during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions in the Dirksen Senate Office Building on June 25, 2025 in Washington, DC.
Kayla Bartkowski | Getty Images
The White House on Wednesday said it had fired Centers for Disease Control and Prevention Director Susan Monarez after she refused to resign. Four other top CDC officials announced they were quitting the embattled health agency.
The leadership crisis at CDC erupted the same day the Food and Drug Administration announced new limits on who can get the latest approved round of Covid vaccines in the U.S.
“Susan Monarez is not aligned with the President’s agenda of Making America Healthy Again,” White House Spokesman Kush Desai said in a statement to NBC News. “Since Susan Monarez refused to resign despite informing [Health and Human Services Department] leadership of her intent to do so, the White House has terminated Monarez from her position with the CDC.”
The statement comes hours after attorney Mark Zaid said he was representing Monarez and that she had not actually been fired yet or stepped down, adding that she would not resign.
“When CDC Director Susan Monarez refused to rubber-stamp unscientific, reckless directives and fire dedicated health experts, she chose protecting the public over serving a political agenda,” Zaid said in a statement. “For that, she has been targeted.”
Earlier on Wednesday, HHS said in a post on X that “Monarez is no longer director” of the agency.
Monarez, a longtime federal government scientist, was sworn in on July 31. She is the first CDC director to be confirmed by the Senate following a new law passed during the pandemic that required lawmakers to approve nominees for the role.
The Washington Post first reported her ousting on Wednesday.
At least four other officials also submitted their resignations on Wednesday in a massive shakeup at the agency: Dr. Debra Houry, the CDC’s chief medical officer; Dr. Demetre Daskalakis, director of the National Center for Immunization and Respiratory Diseases; Dr. Daniel Jernigan, the director of the National Center for Emerging and Zoonotic Infectious Diseases; and Dr. Jennifer Layden, director of the Office of Public Health Data, Surveillance and Technology.
Houry, in a resignation letter obtained by NBC News, wrote about the dangers of the spread of vaccine misinformation and said proposed budget cuts and reorganization plans would negatively impact the CDC’s ability to address conditions like hypertension, diabetes, cancer, overdoses and mental health issues.
In his resignation letter, also obtained by NBC News, Daskalakis said he was leaving the agency “because of the ongoing weaponizing of public health.”
Her departure comes at a tumultuous time for the agency, which is reeling from a gunman’s attack on its Atlanta headquarters on Aug. 8. A police officer died in the shooting.
Monarez on Friday canceled a meeting with CDC workers that had been scheduled for Monday, according to an email obtained by NBC News. She said she wanted to assure staff that the agency is working to restore their “trust in the safety and security of all CDC workplaces.”
President Donald Trump nominated Monarez after withdrawing his first pick to lead the CDC, former Republican congressman Dave Weldon, hours before his confirmation hearing. Weldon has been criticized for his views on vaccines.
— CNBC’s Michele Luhn contributed to this report.
CBI says UK retail sales have been weak in August
Offset opens up on plans to remarry after Cardi B divorce
Indigo Shares Decline Over 4% On Promoter Offloading Stake
-
Tech1 week agoKorea develops core radar components for stealth technology
-
Business1 week agoRSS Feed Generator, Create RSS feeds from URL
-
Fashion7 days agoTariff pressure casts shadow on Gujarat’s textile landscape
-
Fashion7 days agoRent the Runway to swap debt for equity in revival effort
-
jobs1 week agoData Analyst at Easy Agile – Australia
-
Fashion1 week agoUS retailers split on holiday prospects amid consumer caution
-
Tech7 days agoQi2’s Magnetic Wireless Charging Finally Arrives on Android
-
Sports1 week ago
Dan Quinn says Terry McLaurin is healthy, ‘closer’ to Commanders return